Substrate Reduction Therapy for GBA1 ‐Associated Parkinsonism: Are We Betting on the Wrong Mouse?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Substrate Reduction Therapy for GBA1 ‐Associated Parkinsonism: Are We Betting on the Wrong Mouse?

Published:2019-11-11 Issue:2 Volume:35 Page:228-230
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Sidransky Ellen¹^ORCID,Arkadir David²³^ORCID,Bauer Peter⁴,Dinur Tama⁵,Lopez Grisel¹,Rolfs Arndt⁴,Zimran Ari³⁵^ORCID

Affiliation:

1. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health Bethesda Maryland USA

2. Hadassah Medical Center Jerusalem Israel

3. Hebrew University‐Hadassah Medical School Jerusalem Israel

4. Centogene AG Rostock Germany

5. Gaucher Unit, Shaare Zedek Medical Center Jerusalem Israel

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27903

Reference24 articles.

1. Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

2. The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease

3. Gaucher disease: Progress and ongoing challenges

4. How we manage Gaucher Disease in the era of choices

5. Enzyme replacement and substrate reduction therapy for Gaucher disease;Shemesh E;Cochrane Database Syst Rev,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gaucher disease provides a unique window into Parkinson disease pathogenesis;Nature Reviews Neurology;2024-08-06

2. The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics;Brain;2024-03-04

3. Venglustat in GBA1-related Parkinson's disease;The Lancet Neurology;2024-02

4. iPSC-derived neural precursor cells engineering GBA1 recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathology;Molecular Therapy - Methods & Clinical Development;2023-06

5. Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels;Movement Disorders;2022-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3